Next Article in Journal
Epigenetics Role in Spermatozoa Function: Implications in Health and Evolution—An Overview
Next Article in Special Issue
Prostaglandin D2 Added during the Differentiation of 3T3-L1 Cells Suppresses Adipogenesis via Dysfunction of D-Prostanoid Receptor P1 and P2
Previous Article in Journal
Cardiovascular Toxicity Induced by Vascular Endothelial Growth Factor Inhibitors
Previous Article in Special Issue
Alternative Methods as Tools for Obesity Research: In Vitro and In Silico Approaches
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Life
Volume 13
Issue 2
10.3390/life13020367
life-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Arachidonic Acid Added during the Differentiation Phase of 3T3-L1 Cells Exerts Anti-Adipogenic Effect by Reducing the Effects of Pro-Adipogenic Prostaglandins

by
Michael N. N. Nartey
1,2,
Mitsuo Jisaka
1,3,4,*,
Pinky Karim Syeda
3,
Kohji Nishimura
1,3,4,5,
Hidehisa Shimizu
1,3,4,5 and
Kazushige Yokota
1,3,4
1
The United Graduate School of Agricultural Sciences, Tottori University, 4-101 Koyama-Minami, Tottori 680-8553, Japan
2
Council for Scientific and Industrial Research-Animal Research Institute, Achimota, Accra P.O. Box AH20, Ghana
3
Department of Life Science and Biotechnology, Shimane University, 1060 Nishikawatsu-Cho, Shimane, Matsue 690-8504, Japan
4
Institute of Agricultural and Life Sciences, Academic Assembly, Shimane University, 1060 Nishikawatsu-Cho, Shimane, Matsue 690-8504, Japan
5
Interdisciplinary Center for Science Research, Shimane University, 1060 Nishikawatsu-Cho, Shimane, Matsue 690-8504, Japan
*
Author to whom correspondence should be addressed.
Life 2023, 13(2), 367; https://doi.org/10.3390/life13020367
Submission received: 15 December 2022 / Revised: 22 January 2023 / Accepted: 22 January 2023 / Published: 29 January 2023
(This article belongs to the Special Issue New Updates in Adipocytes and Adipose Tissue)
Browse Figures
Versions Notes

Abstract

:
A linoleic acid (LA) metabolite arachidonic acid (AA) added to 3T3-L1 cells is reported to suppress adipogenesis. The purpose of the present study aimed to clarify the effects of AA added during the differentiation phase, including adipogenesis, the types of prostaglandins (PG)s produced, and the crosstalk between AA and the PGs produced. Adipogenesis was inhibited by AA added, while LA did not. When AA was added, increased PGE2 and PGF2α production, unchanged Δ12-PGJ2 production, and reduced PGI2 production were observed. Since the decreased PGI2 production was reflected in decreased CCAAT/enhancer-binding protein-β (C/EBPβ) and C/EBPδ expression, we expected that the coexistence of PGI2 with AA would suppress the anti-adipogenic effects of AA. However, the coexistence of PGI2 with AA did not attenuate the anti-adipogenic effects of AA. In addition, the results were similar when Δ12-PGJ2 coexisted with AA. Taken together, these results indicated that the metabolism of ingested LA to AA is necessary to inhibit adipogenesis and that exposure of AA to adipocytes during only the differentiation phase is sufficient. As further mechanisms for suppressing adipogenesis, AA was found not only to increase PGE2 and PGF2α and decrease PGI2 production but also to abrogate the pro-adipogenic effects of PGI2 and Δ12-PGJ2.

1. Introduction

White adipose tissue is a major metabolic organ responsible for energy homeostasis [1]. The status of adipocytes significantly affects the development of obesity and diabetes [2], two typical noncommunicable diseases that have recently become major problems in developed countries. Preadipocytes in the immediate vicinity of adipocytes in white adipose tissue can alter adipose tissue function by differentiating into adipocytes. Established immortal preadipocyte cell lines such as 3T3-L1 cells have facilitated studies of adipogenesis [3,4]. In general, adipogenesis is initiated in vitro by incubating confluent 3T3-L1 preadipocytes in a medium containing a mixture of 3-isobutyl-1-methylxanthine (IBMX), dexamethasone, and insulin (MDI). MDI triggers the post-confluence mitotic clonal expansion of cells at G0/G1 growth arrest, forcing the cells to exit the cell cycle into terminal differentiation. IBMX and dexamethasone rapidly induce the expression of CCAAT/enhancer-binding protein-β (C/EBPβ) and C/EBPδ, respectively, during the differentiation phase. These transcription factors further induce the expression of the key adipogenic transcription factors C/EBPα and peroxisome proliferator-activated receptor-γ (PPARγ) [5,6,7,8,9] that evokes a positive feedback loop between them PPARγ and C/EBPα [10]. Thereafter, the expression of genes prerequisite to realize the adipocyte phenotype is induced [11,12,13].
Arachidonic acid (AA), an n-6 polyunsaturated fatty acid (n-6 PUFA), is biosynthesized from dietary linoleic acid (LA) and is involved in the production of pro- or anti-adipogenic prostaglandins (PG)s via the metabolism initiated by cyclooxygenase (COX) isoforms, COX-1 and COX-2. Pro-adipogenic PGs include PGI2 [14,15] and the PGJ2 derivatives, 15-deoxy-Δ12,14-PGJ2 (15d-PGJ2) and Δ12-PGJ2 [16,17,18,19]. PGI2 rapidly upregulates C/EBPβ and C/EBPδ expression by activating the IP receptor in preadipocytes [20]. Furthermore, the activation of IP receptors by PGI2 is also suggested to activate PPARγ by activating IP receptors in HEK293 cells [21]. In addition, both 15d-PGJ2 and Δ12-PGJ2 are representative PPARγ activators, which lead to adipogenesis [16,17]. Anti-adipogenic PGs include PGE2 [22,23,24] and PGF2α [25,26]. PGE2 and PGF2α are reported to suppress adipogenesis by activating their G protein-coupled receptors, EP4, and FP receptors, respectively [23,24,25,26].
Over 85% of the total PUFAs consumed in Western diets are n-6 PUFAs, mainly LA, a precursor of AA [27]. The composition of fatty acids in red blood cells from mice fed for 53 days with corn oil that is rich in LA, but without the detectable amount of AA, confirmed that the n-6 PUFAs in the diet were converted to AA [28]. In addition, the effects of n-6 PUFAs on adipose tissue were evaluated based on the balance of dietary carbohydrates and proteins. A higher carbohydrate/protein ratio in the diet results in a higher plasma insulin/glucagon ratio, an environment in which dietary n-6 PUFAs promote adipose tissue expansion [28]. Conversely, a higher protein/carbohydrate ratio in the diet increases the plasma glucagon/insulin ratio and promotes cAMP-dependent signaling. The synthesis of PGE2 and PGF2α mediated by COX is enhanced in this environment, and these PGs reduce white adipose tissue mass [28]. The balance of carbohydrates and proteins in the diet affected cAMP levels in adipocytes in the experimental animals.
Because IBMX is a cAMP-elevating agent, incubation of 3T3-L1 cells with this compound during the differentiation phase may mimic the high protein/carbohydrate ratio in the diet. Indeed, adipogenesis is promoted when 3T3-L1 cells are incubated during the differentiation phase with AA, dexamethasone, and insulin, except IBMX [28,29,30]. The biosynthesis of PGE2 and PGF2α is decreased, whereas that of PGI2 is increased under these culture conditions [30]. In contrast, adding MDI and AA during the differentiation phase of 3T3-L1 cells increases the biosynthesis of PGE2 and PGF2α [28,31], and suppresses MDI-induced adipogenesis [28,29,31]. However, because there are no reports on which prostaglandins other than PGE2 and PGF2α are produced by AA added during the differentiation phase, nor on how the crosstalk between PGs produced and AA during the differentiation phase affects adipogenesis, the present study thus aimed to analyze these points. Furthermore, since LA has pro-adipogenic effects in the absence of IBMX during the differentiation phase of 3T3-L1 cells [30], we examined the effect of LA in the presence of IBMX.

2. Materials and Methods

2.1. Materials

Dulbecco’s modified Eagle medium containing 25 mM HEPES (DMEM-HEPES), penicillin G potassium salt, streptomycin sulfate, dexamethasone, fatty acid-free bovine serum albumin, and recombinant human insulin was obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). L-Ascorbic acid phosphate magnesium salt n-hydrate, and 3-isobutyl-1-methylxanthine (IBMX) were from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Fetal bovine serum (FBS) was purchased from MP Biomedicals (Solon, OH, USA). AA, LA, PGE2, PGF2α, Δ12-PGJ2, and 6-keto-PGF1α were from Cayman Chemical (Ann Arbor, MI, USA). We purchased M-MLV reverse transcriptase (point mutation without Ribonuclease H activity) from Promega (Madison, WI, USA). Oligonucleotides for real-time quantitative (RT-q) PCR amplification were provided by Sigma Genosys Japan (Ishikari, Japan).

2.2. Culture of 3T3-L1 Cells and Induction of Adipogenesis

Mouse 3T3-L1 pre-adipogenic cells (JCRB9014; JCRB Cell Bank, Osaka, Japan) in the growth phase were seeded at a density of 1 × 105 or 2 × 105 in 35 or 60 mm dishes containing 2 or 4 mL, respectively, of growth medium (GM; DMEM-HEPES supplemented with 10% FBS, penicillin G [100 units/mL], streptomycin sulfate [100 μg/L], and ascorbic acid [200 μM]), then incubated at 37 °C under 7% CO2 until they reached confluence. Confluent monolayers were incubated with differentiation medium (DM; GM supplemented with dexamethasone [1 μM], IBMX [0.5 mM], and insulin [10 μg/mL]) for 6–48 h to induce differentiation into adipocytes. The cells were then incubated for 6–10 days in maturation medium (MM; GM supplemented with insulin [5 μg/mL]). The medium was replaced with fresh MM every 2 days to promote the accumulation of fat in 3T3-L1 cells during maturation. We examined the effects of various agents added during differentiation on adipogenesis by incubating confluent cell monolayers in DM supplemented with test compounds for 6–48 h, followed by the standard maturation protocol. The test compounds were dissolved in ethanol and added to the DM to a final ethanol concentration of 0.2%.

2.3. Quantification of Intracellular TAGs and Cellular Proteins

Cultured mature adipocytes were harvested, suspended in phosphate-buffered saline (PBS) without Ca2+ and Mg2+ (PBS [–]) supplemented with 0.05% trypsin and 0.53 mM EDTA, and incubated at 37 °C for 5 min. The resulting cell suspensions were washed with PBS (-), divided into two portions, and homogenized in 25 mM Tris-HCl buffer (pH 7.4) containing 1 mM EDTA and 1 N NaOH. Amounts of intracellular TAGs were quantified in one portion using Triglyceride E-Test Kits (Wako). Cellular proteins were precipitated in the other portion with ice-chilled 6% trichloroacetic acid to remove interfering substances and then quantified using the Lowry method with fatty acid-free bovine serum albumin as a standard. Amounts of intracellular TAGs were normalized to the protein content and are expressed as relative amounts of accumulated intracellular TAGs.

2.4. Quantification of PGs by ELISA

Levels of PGE2, PGF2α, Δ12-PGJ2, and 6-keto-PGF1α were measured in the DM containing IBMX in the presence 50 μM AA for 48 h. We quantified PGE2 by ELISA specific for PGE2 as described [32]. A PGE2-conjugate and fatty acid-free bovine serum albumin were immobilized in 96-well microplates. Immobilized antigen in standards or test samples was competitively incubated with diluted mouse monoclonal antibody specific for PGE2. The resultant immunocomplex was detected spectrophotometrically by monitoring the peroxidase activity using o-phenylenediamine as a substrate after binding to biotin-conjugated rabbit anti-mouse IgG antibody and ExtrAvidin peroxidase conjugate as described [33]. We determined the amounts of Δ12-PGJ2 using monoclonal antibodies specific for Δ12-PGJ2. Polyclonal mouse antisera specific for PGF2α and 6-keto-PGF1α that reflect PGI2 biosynthesis were used to develop solid-phase ELISA for the corresponding immobilized antigens as described [34]. Standard curves were generated in fresh DM containing IBMX to quantify PGs including PGE2, PGF2α, Δ12-PGJ2, and 6-keto-PGF1α, which were biosynthesized during differentiation.

2.5. Quantification of Gene Expression

Total RNA (1 μg) extracted from the cells after 6, 24, and 48 h of the differentiation phase, and on day 6 of the maturation phase using acid guanidium thiocyanate/phenol/chloroform was reverse transcribed (RT) using M-MLV reverse transcriptase (Point mutation without Ribonuclease H activity). Single-stranded cDNA was synthesized using oligo-(dT)15 and a random 9-mer (Promega) as primers in the RT reaction. Transcript levels were determined by RT-qPCR using TB GreenTM Premix Ex TaqTM II (Tli RNaseH Plus) kits (Takara Bio Co., Inc., Kusatsu, Japan) and a Thermal Cycler DiceTM Real Time System (Takara Bio Co., Inc.) according to the threshold cycle (CT) and ΔΔCT methods described by the manufacturer. Table 1 shows the oligonucleotides used herein. The cycling program comprised 95 °C for 30 s, 40 cycles at 95 °C for 5 s and 60 °C for 30 s, followed by 95 °C for 15 s and 60 °C for 30 s. Levels of target gene transcripts were determined and normalized to those of β-Actin. The accession numbers of the target genes are as follows: C/Ebpβ, NM_009883; C/Ebpδ, NM_007679; Pparγ, NM_011146; C/Ebpα, NM_001287523; Lpl, NM_008509; Glut4, AB008453; Leptin, NM_008493; β-Actin, NM_007393.

2.6. Statistical Analyses

All results are expressed as means ± standard error of the mean (SEM). Data were statistically analyzed by Dunnett tests, Student t-tests, and Tukey-Kramer tests using Excel 2011 (Microsoft Corp., Redmond, WA, USA) and Statcel 4 (OMS Publishing Co., Saitama, Japan). Values with p < 0.05 were considered statistically significant.

3. Results

3.1. Effects of AA or LA Added during Only the Differentiation Phase of 3T3-L1 Cells on MDI-Induced Adipogenesis

The present study examined whether AA added during the differentiation phase affects the anti-adipogenic effects following the procedure in Figure 1A. As an indicator for adipogenic differentiation of 3T3-L1 cells, we evaluated intracellular TAG accumulation. AA added up to 100 µM during the differentiation phase of 3T3-L1 cells dose-dependently reduced the accumulation of intracellular TAG in MDI-induced mature adipocytes (Figure 1B). Due to the fact that 50 µM AA was sufficient to be effective, we used this concentration in subsequent analyses. We next checked whether LA, like AA, also suppresses MDI-induced adipogenesis following the procedure in Figure 1A because AA in humans is largely produced from LA ingested in the diet. Figure 1C shows that LA, unlike AA, added during the differentiation phase did not inhibit the accumulation of intracellular TAG in MDI-induced mature adipocytes. These results indicated that the metabolic conversion of LA to AA is needed to suppress the accumulation of intracellular TAG during maturation induced by MDI. In addition, if 3T3-L1 cells are exposed to AA during the differentiation phase, its anti-adipogenic effects can be sufficiently exerted even without exposure to AA during the maturation phase.

3.2. Types of PGs Biosynthesized by Adding AA during Only the Differentiation Phase of 3T3-L1 Cells and Effects of PGs Added during Only the Differentiation Phase on MDI-Induced Adipogenesis

We evaluated what PGs were produced by adding AA during the differentiation phase. Analysis performed according to the procedure in Figure 2A confirmed the elevated PGE2 and PGF2α production, similar to previous reports (Figure 2B,C) [28,31]. Since the production of other PGs is unknown, we checked whether other PGs are also synthesized. The production of Δ12-PGJ2 was not altered under these conditions (Figure 2D), while that of PGI2-derived 6-keto-PGF1α was decreased, suggesting decreased PGI2 production (Figure 2E). As PGI2 is rapidly degraded to stable 6-keto-PGF1α, the amount of 6-keto-PGF1α reflects that of PGI2 [34]. Based on the results of Figure 2, we examined how MDI-induced adipogenesis would be affected if 3T3-L1 cells responded to PGs during only the differentiation phase (Figure 3A). PGE2 and PGF2α added during the differentiation phase inhibited MDI-induced adipogenesis during the maturation phase (Figure 3B). On the other hand, Δ12-PGJ2, and PGI2 added during the differentiation phase promoted MDI-induced adipogenesis during the maturation phase (Figure 3B). Together with the results in Figure 2, the suppression of MDI-induced adipogenesis during the maturation phase by AA added during the differentiation phase may be due not only to increased anti-adipogenic PGE2 and PGF2α but also to reduced pro-adipogenic PGI2 production during the differentiation phase.

3.3. Adipogenesis-Related Gene Expression in Response to AA during the Differentiation Phase

Although endogenous PGI2 has a very short chemical lifespan [35], we found that PGI2 induces adipogenesis by activating IP receptors in an autocrine fashion before spontaneous degradation [30]. Furthermore, PGI2 added during the differentiation phase significantly promoted the adipogenesis of 3T3-L1 cells (Figure 3B). Therefore, since the results in Figure 2E suggested that AA decreased PGI2 production, we predicted that induction of the MDI-induced adipogenic program would be suppressed, starting with activated IP receptor to increase C/Ebpβ and C/Ebpδ expression [20]. The expression of C/Ebpβ and C/Ebpδ was analyzed as described in Figure 4A. The RT-qPCR findings show that AA added during the differentiation phase reduced the expression of C/Ebpβ and C/Ebpδ which are critical for the progression of the early phase of adipogenesis (Figure 4B,C). Since C/Ebpβ and C/Ebpδ levels affect the expression of Pparγ and C/Ebpα, master regulators of adipogenesis [5,6,7,8,9], we analyzed their expression as described in Figure 5A. The RT-qPCR revealed reduced Pparγ and C/Ebpα expression, which should result from the downregulation of C/Ebpβ and C/Ebpδ (Figure 5B,C). Due to the fact that AA decreased the expression of these transcription factors involved in adipogenesis, we further analyzed the expression of the established adipocyte-specific marker genes, lipoprotein lipase (Lpl), glucose transporter 4 (Glut4), and Leptin by RT-qPCR as described in Figure 6A–D show downregulated expression of Lpl, Glut4, and Leptin. Taken together, these results suggest that AA added during the differentiation phase may attenuate the activation of the IP receptor by PGI2 and prevent the progression of the early phase of adipogenesis triggered by C/EBPβ and C/EBPδ increased otherwise.

3.4. Effects of AA Coexistent with Pro-Adipogenic PGs during the Differentiation Phase of 3T3-L1 Cells on MDI-Induced Adipogenesis

Since the production of PGI2 during the differentiation phase was reduced by the addition of AA (Figure 2E), we examined whether the inhibition of MDI-induced adipogenesis during the maturation phase by AA is alleviated by the coexistence of PGI2 with AA during only the differentiation phase (Figure 7A). Although addition of PGI2 during the differentiation phase promoted MDI-induced adipogenesis during the maturation phase (Figure 3B), the addition of PGI2 with AA during the differentiation phase was not able to rescue AA-stimulated inhibition of adipogenesis (Figure 7B). In addition, although the production of PPARγ activator, Δ12-PGJ2, during the differentiation phase was not changed by the addition of AA (Figure 2D), we also evaluated whether pro-adipogenic PGs other than PGI2 influence the AA-elicited inhibition of MDI-induced adipogenesis during the maturation phase (Figure 7A). As the case of PGI2, pro-adipogenic Δ12-PGJ2 (Figure 3B) was not able to rescue AA-stimulated inhibition of adipogenesis when Δ12-PGJ2 coexisted with AA during the differentiation phase (Figure 7B). Taken together, these results indicate that pro-adipogenic PGs production during the differentiation phase does not influence the suppression of MDI-induced adipogenesis during the maturation phase by adding AA during the differentiation phase.

4. Discussion

Figure 8 summarizes the present findings. In line with previous findings reported by other groups [28,29,31], the present study confirmed that AA added during the differentiation phase of 3T3-L1 cells inhibited MDI-induced adipogenesis during the maturation phase and elicited anti-adipogenic PGE2 and PGF2α production. The novel findings are as follows: (1) LA added during only the differentiation phase did not inhibit MDI-induced adipogenesis during the maturation phase, even though LA is a precursor of AA; (2) Δ12-PGJ2 production was not affected by AA added during the differentiation phase; (3) PGI2 production was decreased by AA added during the differentiation phase, which in turn suppressed the progression of the adipogenic program initiated by increased C/Ebpβ and C/Ebpδ expression; (4) the addition of PGI2 or Δ12-PGJ2 with AA during the differentiation phase did not influence the AA-induced inhibition of MDI-induced adipogenesis during the maturation phase. Taken together, in addition to the alteration of PGs production, the inhibitory effects of AA on the actions of pro-adipogenic PGs during the differentiation phase may play an important role in the suppression of MDI-induced adipogenesis during the maturation phase.
Ingested LA must be metabolized to AA to affect white adipocytes in vivo [28]. The present and other studies have shown that AA participates in the inhibition of adipogenesis [28,29,31]. However, whether LA affects adipocytes in the same way as AA remains unclear. Our findings indicated that LA, unlike AA, did not inhibit adipogenesis induced by MDI, even though it is a precursor of AA. Thus, the present findings indicate that a reduction in white adipose tissue mass associated with ingesting LA from a high-protein/low-carbohydrate diet is due to the action of AA, and not LA. Furthermore, the present study indicates that the anti-adipogenic effects of AA are fully exerted when adipocytes are exposed to AA during the differentiation phase.
When AA is added to 3T3-L1 cells during the differentiation phase without IBMX, production of PGE2 and PGF2α was decreased, while that of PGI2 increases in the phase, promoting the accumulation of intracellular TAG levels after maturation [30]. In contrast, the present study found that AA added during the differentiation phase with IBMX suppressed the accumulation of intracellular TAG levels after maturation. We also found increased PGE2 and PGF2α, and decreased PGI2 production in the differentiation phase. The only difference between the previous and the present studies is the presence or absence of IBMX added during the differentiation phase. Since IBMX is a cAMP-elevating agent, the difference in the types of PGs produced in the previous and current studies should be produced by cAMP-activated protein kinase A (PKA) or exchange protein directly activated by cAMP (Epac). Activation of both Epac and PKA during the differentiation phase contributes to MDI-induced adipogenesis [36,37], whereas activation of only PKA suppresses it [38]. Since MDI-induced adipogenesis was suppressed in the present study, only PKA may have been activated by adding IBMX in the presence of AA. In fact, the coexistence of H89, an inhibitor of PKA, with AA during the differentiation phase is reported to suppress the anti-adipogenic effects of AA [28]. Thus, during the differentiation phase, the change in PG production by adding AA depends on the presence of IBMX, suggesting the effect of PKA activation.
Since reduced PGI2 production leads to decreased C/Ebpβ and C/Ebpδ expression [15], we speculated that not only the rise in both anti-adipogenic PGs, PGE2, and PGF2α, but also the reduction in PGI2 production, by AA added during the differentiation phase was also responsible for the suppression of MDI-induced adipogenesis during the maturation phase. However, the inhibition of MDI-induced adipogenesis by AA during the maturation phase was not alleviated by the coexistence of PGI2 with AA during the differentiation phase. Based on these results, we also examined other pro-adipogenic PG, Δ12-PGJ2, and found similar results. These results proposed that the property of AA to nullify the effects of adipogenic PGs is the most significant factor leading to anti-adipogenic effects. Therefore, we speculate that the decreased Pparγ expression observed in the present study was primarily caused by the reduced PPARγ transcriptional activity rather than the reduced PGI2 production induced by AA. The reason supporting the speculation that decreased PPARγ transcriptional activity leads to decreased Pparγ expression is that PPARγ has an auto-loop mechanism with C/EBPα, and their transcriptional activity and expression levels correlate with each other [10]. In fact, this mechanism may be at work as well since a reduction in both Pparγ and C/Ebpα expression was observed in the present study. Reduced PPARγ transcriptional activity is induced by its phosphorylation through MAPK activation, and PGF2α triggers this mechanism [39]. The observed increase in PGF2α production induced by AA added during the differentiation phase in the present study may cause the decreased Pparγ expression through this mechanism. Furthermore, PGE2 also contributes to PGF2α production by increasing COX-2 expression [40]. Based on these results, the increased PGE2 production induced by AA added during the differentiation phase may suppress MDI-induced adipogenesis during the maturation phase through the same mechanism as PGF2α described above. A morphological evaluation of the effect of the addition of AA to the 3T3-L1 cells during the differentiation phase on adipogenesis, such as the size of intracellular lipid droplets as well as the shape and size of adipocytes, could provide us with a better understanding of the molecular mechanism governing the anti-adipogenic function of AA during the early phase of adipocyte differentiation. Since the above action mechanisms of AA are our speculation, further study will be needed in the future.

5. Conclusions

The present findings indicate that differentiation of cultured 3T3-L1 pre-adipocytes to matured adipocytes is attenuated by the addition of AA, but not LA, during the differentiation phase. The anti-adipogenic effects of AA could be explained, at least partially, by alteration in PG synthesis during the differentiation phase. The addition of AA increased anti-adipogenic PGE2 and PGF2α, while decreasing or not affecting pro-adipogenic PGI2 and Δ12-PGJ2. The addition of AA also decreased the expression of the differentiation-initiating genes, C/Ebpβ and C/Ebpδ, which could, by cooperating with the alteration in PG synthesis, decrease the expression of the following master-regulator genes, Pparγ and C/Ebpα, and finally the adipocyte-specific marker genes, Lpl, Glut4, and Leptin. AA should affect the very initiating steps in the differentiation as confirmed by the results that coexisting PGI2 or Δ12-PGJ2 did not cancel the AA-induced suppression of adipogenesis. PG synthesis is regulated by PKA: the presence of cAMP-increasing IBMX increases anti-adipogenic PGs, while its absence increases the production of pro-adipogenic PGs [30]. Therefore, controlling PKA activity by feeding, for example, the balance of carbohydrates and proteins in the diet, could be a determining factor for the effects of AA on the development of adipose tissue.

Author Contributions

Conceptualization, M.J. and K.Y.; formal analysis, M.N.N.N. and K.Y.; investigation, M.N.N.N., M.J., P.K.S., K.N., H.S. and K.Y.; writing—original draft preparation, H.S.; writing—review and editing, M.N.N.N., M.J., P.K.S., K.N. and H.S.; supervision, M.J. and K.Y.; project administration, M.N.N.N.; funding acquisition, K.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by Grants-in-Aid for Scientific Research (C) (Grant Number JP25450128 to K.Y.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Norma Foster for their help with manuscript preparation. The authors are grateful to the Faculty of Life and Environmental Sciences at Shimane University for providing financial support for the publication of this report.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bennett, C.N.; Ross, S.E.; Longo, K.A.; Bajnok, L.; Hemati, N.; Johnson, K.W.; Harrison, S.D.; MacDougald, O.A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 2002, 277, 30998–31004. [Google Scholar] [CrossRef] [Green Version]
  2. Kopelman, P.G. Obesity as a medical problem. Nature 2000, 404, 635–643. [Google Scholar] [CrossRef] [PubMed]
  3. Green, H.; Kehinde, O. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1974, 1, 113–116. [Google Scholar] [CrossRef]
  4. Green, H.; Kehinde, O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5, 19–27. [Google Scholar] [CrossRef] [PubMed]
  5. Cao, Z.; Umek, R.M.; McKnight, S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991, 5, 1538–1552. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Wu, Z.; Xie, Y.; Bucher, N.L.; Farmer, S.R. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev. 1995, 9, 2350–2363. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Yeh, W.C.; Cao, Z.; Classon, M.; McKnight, S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 1995, 9, 168–181. [Google Scholar] [CrossRef] [Green Version]
  8. Wu, Z.; Bucher, N.L.; Farmer, S.R. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol. Cell. Biol. 1996, 16, 4128–4136. [Google Scholar] [CrossRef] [Green Version]
  9. Tzameli, I.; Fang, H.; Ollero, M.; Shi, H.; Hamm, J.K.; Kievit, P.; Hollenberg, A.N.; Flier, J.S. Regulated production of a peroxisome proliferator-activated receptor-γ ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J. Biol. Chem. 2004, 279, 36093–36102. [Google Scholar] [CrossRef] [Green Version]
  10. Wu, Z.; Rosen, E.D.; Brun, R.; Hauser, S.; Adelmant, G.; Troy, A.E.; McKeon, C.; Darlington, G.J.; Spiegelman, B.M. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 1999, 3, 151–158. [Google Scholar] [CrossRef]
  11. MacDougald, O.A.; Lane, M.D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 1995, 64, 345–373. [Google Scholar] [CrossRef]
  12. Lowell, B.B. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function. Cell 1999, 99, 239–242. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Rosen, E.D.; Spiegelman, B.M. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 2000, 16, 145–171. [Google Scholar] [CrossRef] [PubMed]
  14. Massiera, F.; Saint-Marc, P.; Seydoux, J.; Murata, T.; Kobayashi, T.; Narumiya, S.; Guesnet, P.; Amri, E.Z.; Negrel, R.; Ailhaud, G. Arachidonic acid and prostacyclin signaling promote adipose tissue development: A human health concern? J. Lipid Res. 2003, 44, 271–279. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Rahman, M.S. Prostacyclin: A major prostaglandin in the regulation of adipose tissue development. J. Cell Physiol. 2019, 234, 3254–3262. [Google Scholar] [CrossRef] [PubMed]
  16. Forman, B.M.; Tontonoz, P.; Chen, J.; Brun, R.P.; Spiegelman, B.M.; Evans, R.M. 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995, 83, 803–812. [Google Scholar] [CrossRef] [Green Version]
  17. Kliewer, S.A.; Lenhard, J.M.; Willson, T.M.; Patel, I.; Morris, D.C.; Lehmann, J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995, 83, 813–819. [Google Scholar] [CrossRef] [Green Version]
  18. Mazid, M.A.; Chowdhury, A.A.; Nagao, K.; Nishimura, K.; Jisaka, M.; Nagaya, T.; Yokota, K. Endogenous 15-deoxy-Δ12,14-prostaglandin J2 synthesized by adipocytes during maturation phase contributes to upregulation of fat storage. FEBS Lett. 2006, 580, 6885–6890. [Google Scholar] [CrossRef] [Green Version]
  19. Hossain, M.S.; Chowdhury, A.A.; Rahman, M.S.; Nishimura, K.; Jisaka, M.; Nagaya, T.; Shono, F.; Yokota, K. Development of enzyme-linked immunosorbent assay for Δ12-prostaglandin J2 and its application to the measurement of endogenous product generated by cultured adipocytes during the maturation phase. Prostaglandins Other Lipid Mediat. 2011, 94, 73–80. [Google Scholar] [CrossRef]
  20. Aubert, J.; Saint-Marc, P.; Belmonte, N.; Dani, C.; Négrel, R.; Ailhaud, G. Prostacyclin IP receptor up-regulates the early expression of C/EBPβ and C/EBPδ in preadipose cells. Mol. Cell. Endocrinol. 2000, 160, 149–156. [Google Scholar] [CrossRef]
  21. Falcetti, E.; Flavell, D.M.; Staels, B.; Tinker, A.; Haworth, S.G.; Clapp, L.H. IP receptor-dependent activation of PPARγ by stable prostacyclin analogues. Biochem. Biophys. Res. Commun. 2007, 360, 821–827. [Google Scholar] [CrossRef]
  22. Sugimoto, Y.; Tsuboi, H.; Okuno, Y.; Tamba, S.; Tsuchiya, S.; Tsujimoto, G.; Ichikawa, A. Microarray evaluation of EP4 receptor-mediated prostaglandin E2 suppression of 3T3-L1 adipocyte differentiation. Biochem. Biophys. Res. Commun. 2004, 322, 911–917. [Google Scholar] [CrossRef]
  23. Tsuboi, H.; Sugimoto, Y.; Kainoh, T.; Ichikawa, A. Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation. Biochem. Biophys. Res. Commun. 2004, 322, 1066–1072. [Google Scholar] [CrossRef] [PubMed]
  24. Inazumi, T.; Shirata, N.; Morimoto, K.; Takano, H.; Segi-Nishida, E.; Sugimoto, Y. Prostaglandin E2-EP4 signaling suppresses adipocyte differentiation in mouse embryonic fibroblasts via an autocrine mechanism. J. Lipid Res. 2011, 52, 1500–1508. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Miller, C.W.; Casimir, D.A.; Ntambi, J.M. The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2α. Endocrinology 1996, 137, 5641–5650. [Google Scholar] [CrossRef]
  26. Fujimori, K.; Ueno, T.; Nagata, N.; Kashiwagi, K.; Aritake, K.; Amano, F.; Urade, Y. Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2α synthase. J. Biol. Chem. 2010, 285, 8880–8886. [Google Scholar] [CrossRef] [Green Version]
  27. Simopoulos, A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 2002, 56, 365–379. [Google Scholar] [CrossRef] [PubMed]
  28. Madsen, L.; Pedersen, L.M.; Liaset, B.; Ma, T.; Petersen, R.K.; van den Berg, S.; Pan, J.; Müller-Decker, K.; Dülsner, E.D.; Kleemann, R.; et al. cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids. J. Biol. Chem. 2008, 283, 7196–7205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Petersen, R.K.; Jørgensen, C.; Rustan, A.C.; Frøyland, L.; Muller-Decker, K.; Furstenberger, G.; Berge, R.K.; Kristiansen, K.; Madsen, L. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J. Lipid Res. 2003, 44, 2320–2330. [Google Scholar] [CrossRef] [Green Version]
  30. Khan, F.; Syeda, P.K.; Nartey, M.N.; Rahman, M.S.; Islam, M.S.; Nishimura, K.; Jisaka, M.; Shono, F.; Yokota, K. Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase. Prostaglandins Other Lipid Mediat. 2016, 123, 16–27. [Google Scholar] [CrossRef]
  31. Nikolopoulou, E.; Papacleovoulou, G.; Jean-Alphonse, F.; Grimaldi, G.; Parker, M.G.; Hanyaloglu, A.C.; Christian, M. Arachidonic acid-dependent gene regulation during preadipocyte differentiation controls adipocyte potential. J. Lipid Res. 2014, 55, 2479–2490. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Syeda, P.K.; Hossain, M.S.; Chowdhury, A.A.; Rahman, M.S.; Nishimura, K.; Jisaka, M.; Nagaya, T.; Shono, F.; Yokota, K. Generation of monoclonal antibody for 15-deoxy-Δ12,14-prostaglandin J2 and development of enzyme-linked immunosorbent assay for its quantification in culture medium of adipocytes. Appl. Biochem. Biotechnol. 2012, 167, 1107–1118. [Google Scholar] [CrossRef] [PubMed]
  33. Yokota, K.; Morishima, T.; Nagaya, T.; Jisaka, M.; Takinami, K. Modification of cultured Madin-Darby canine kidney cells with dietary unsaturated fatty acids and regulation of arachidonate cascade reaction. Biosci. Biotechnol. Biochem. 1996, 60, 1096–1103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Rahman, M.S.; Khan, F.; Syeda, P.K.; Nishimura, K.; Jisaka, M.; Nagaya, T.; Shono, F.; Yokota, K. Endogenous synthesis of prostacyclin was positively regulated during the maturation phase of cultured adipocytes. Cytotechnology 2014, 66, 635–646. [Google Scholar] [CrossRef] [Green Version]
  35. Kelton, J.G.; Blajchman, M.A. Prostaglandin I2 (prostacyclin). Can. Med. Assoc. J. 1980, 122, 175–179. [Google Scholar] [PubMed]
  36. Ji, Z.; Mei, F.C.; Cheng, X. Epac, not PKA catalytic subunit, is required for 3T3-L1 preadipocyte differentiation. Front. Biosci. (Elite Ed.) 2010, 2, 392–398. [Google Scholar] [CrossRef] [Green Version]
  37. Gabrielli, M.; Martini, C.N.; Brandani, J.N.; Iustman, L.J.; Romero, D.G.; del, C. Vila, M. Exchange protein activated by cyclic AMP is involved in the regulation of adipogenic genes during 3T3-L1 fibroblasts differentiation. Dev. Growth Differ. 2014, 56, 143–151. [Google Scholar] [CrossRef]
  38. Li, F.; Wang, D.; Zhou, Y.; Zhou, B.; Yang, Y.; Chen, H.; Song, J. Protein kinase A suppresses the differentiation of 3T3-L1 preadipocytes. Cell Res. 2008, 18, 311–323. [Google Scholar] [CrossRef] [Green Version]
  39. Reginato, M.J.; Krakow, S.L.; Bailey, S.T.; Lazar, M.A. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. J. Biol. Chem. 1998, 273, 1855–1858. [Google Scholar] [CrossRef] [Green Version]
  40. Fujimori, K.; Yano, M.; Ueno, T. Synergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α. PLoS ONE 2012, 7, e44698. [Google Scholar] [CrossRef]
Life 13 00367 g001 550
Figure 1. Effects of AA or LA added during the differentiation phase of 3T3-L1 cells on intracellular TAG levels after maturation. (A) Experimental procedure. We seeded 3T3-L1 cells (1 × 105/dish) in 35 mm dishes containing 2 mL of GM and incubated them until they reached 100% confluence. Confluent cells were cultured for 48 h in 2 mL of DM-containing vehicle, indicated concentrations of AA, or LA (50 µM), followed by 2 mL of fresh MM every 2 days for 10 days. Intracellular TAG levels were analyzed in terminally differentiated mature adipocytes collected on day 10. (B,C) Intracellular TAG levels in cultured adipocytes. Data represent means ± SEM of n = 3 experiments for (B,C). * p < 0.05 vs. control (vehicle in DM) (Dunnett tests). GM, growth medium; DM, differentiation medium; MM, maturation medium; AA, arachidonic acid; LA, linoleic acid; TAG, triacylglycerol; SEM, standard error of the mean.
Figure 1. Effects of AA or LA added during the differentiation phase of 3T3-L1 cells on intracellular TAG levels after maturation. (A) Experimental procedure. We seeded 3T3-L1 cells (1 × 105/dish) in 35 mm dishes containing 2 mL of GM and incubated them until they reached 100% confluence. Confluent cells were cultured for 48 h in 2 mL of DM-containing vehicle, indicated concentrations of AA, or LA (50 µM), followed by 2 mL of fresh MM every 2 days for 10 days. Intracellular TAG levels were analyzed in terminally differentiated mature adipocytes collected on day 10. (B,C) Intracellular TAG levels in cultured adipocytes. Data represent means ± SEM of n = 3 experiments for (B,C). * p < 0.05 vs. control (vehicle in DM) (Dunnett tests). GM, growth medium; DM, differentiation medium; MM, maturation medium; AA, arachidonic acid; LA, linoleic acid; TAG, triacylglycerol; SEM, standard error of the mean.
Life 13 00367 g001
Life 13 00367 g002 550
Figure 2. Effect of AA added during the differentiation phase of 3T3-L1 cells on endogenous PG biosynthesis. (A) Experimental procedure. We seeded 3T3-L1 cells (1 × 105/dish) in 35 mm dishes containing 2 mL of GM and cultured them until they reached 100% confluence. Confluent cells were cultured for 48 h in 2 mL of DM-containing vehicle or AA (50 µM). The culture media was collected to determine PGs. (B) PGE2, (C) PGF2α, (D) Δ12-PGJ2, (E) 6-keto-PGF1α assessed by ELISA using specific antibodies. Data are shown as means ± SEM of n = 3 experiments for (B–E). * p < 0.05 vs. control (vehicle in DM) (Student t-tests). GM, growth medium; DM, differentiation medium; AA, arachidonic acid; PG, prostaglandin; PGE2, prostaglandin E2; PGF2α, prostaglandin F2α; Δ12-PGJ2, Δ12-prostaglandin J2; 6-keto-PGF1α, 6-keto-prostaglandin F1α; SEM, standard error of the mean.
Figure 2. Effect of AA added during the differentiation phase of 3T3-L1 cells on endogenous PG biosynthesis. (A) Experimental procedure. We seeded 3T3-L1 cells (1 × 105/dish) in 35 mm dishes containing 2 mL of GM and cultured them until they reached 100% confluence. Confluent cells were cultured for 48 h in 2 mL of DM-containing vehicle or AA (50 µM). The culture media was collected to determine PGs. (B) PGE2, (C) PGF2α, (D) Δ12-PGJ2, (E) 6-keto-PGF1α assessed by ELISA using specific antibodies. Data are shown as means ± SEM of n = 3 experiments for (B–E). * p < 0.05 vs. control (vehicle in DM) (Student t-tests). GM, growth medium; DM, differentiation medium; AA, arachidonic acid; PG, prostaglandin; PGE2, prostaglandin E2; PGF2α, prostaglandin F2α; Δ12-PGJ2, Δ12-prostaglandin J2; 6-keto-PGF1α, 6-keto-prostaglandin F1α; SEM, standard error of the mean.
Life 13 00367 g002
Life 13 00367 g003 550
Figure 3. Effects of PGs added during the differentiation phase of 3T3-L1 cells on intracellular TAG levels after maturation. (A) Experimental procedure. We seeded 3T3-L1 cells (1 × 105/dish) in 35 mm dishes containing 2 mL of GM and incubated them until they reached 100% confluence. Confluent cells were cultured for 48 h in 2 mL of DM-containing vehicle, PGE2 (1 µM), PGF2α (1 µM), Δ12-PGJ2 (1 µM), or PGI2. Na (100 nM), followed by 2 mL of fresh MM every 2 days for 10 days. Intracellular TAG levels were analyzed in terminally differentiated mature adipocytes collected on day 10. (B) Intracellular TAG levels in cultured adipocytes. Data represent means ± SEM of n = 3 experiments for (B). * p < 0.05 vs. control (vehicle in DM) (Dunnett tests). GM, growth medium; DM, differentiation medium; MM, maturation medium; PG, prostaglandin; PGE2, prostaglandin E2; PGF2α, prostaglandin F2α; Δ12-PGJ2, Δ12-prostaglandin J2; PGI2.Na, prostaglandin I2.Na; TAG, triacylglycerol; SEM, standard error of the mean.
Figure 3. Effects of PGs added during the differentiation phase of 3T3-L1 cells on intracellular TAG levels after maturation. (A) Experimental procedure. We seeded 3T3-L1 cells (1 × 105/dish) in 35 mm dishes containing 2 mL of GM and incubated them until they reached 100% confluence. Confluent cells were cultured for 48 h in 2 mL of DM-containing vehicle, PGE2 (1 µM), PGF2α (1 µM), Δ12-PGJ2 (1 µM), or PGI2. Na (100 nM), followed by 2 mL of fresh MM every 2 days for 10 days. Intracellular TAG levels were analyzed in terminally differentiated mature adipocytes collected on day 10. (B) Intracellular TAG levels in cultured adipocytes. Data represent means ± SEM of n = 3 experiments for (B). * p < 0.05 vs. control (vehicle in DM) (Dunnett tests). GM, growth medium; DM, differentiation medium; MM, maturation medium; PG, prostaglandin; PGE2, prostaglandin E2; PGF2α, prostaglandin F2α; Δ12-PGJ2, Δ12-prostaglandin J2; PGI2.Na, prostaglandin I2.Na; TAG, triacylglycerol; SEM, standard error of the mean.
Life 13 00367 g003
Life 13 00367 g004 550
Figure 4. Effects of AA added during the differentiation phase of 3T3-L1 cells on expression of C/Ebpβ and C/Ebpδ. (A) Experimental procedure. We seeded 3T3-L1 cells (2 × 105/dish) in 60 mm dishes containing 4 mL of GM and incubated them until they reached confluence. Thereafter, cells were incubated with DM containing vehicle or AA (50 µM) during the differentiation phase for 6 h. Expression of mRNA for (B) C/Ebpβ and (C) C/Ebpδ determined by RT-qPCR. Data are shown as means ± SEM of n = 3 experiments for (B,C). * p < 0.05 vs. control (vehicle in DM) (Student t-tests). GM, growth medium; DM, differentiation medium; AA, arachidonic acid; C/Ebpβ, CCAAT/enhancer-binding protein-β; C/Ebpδ, CCAAT/enhancer-binding protein-δ; SEM, standard error of the mean.
Figure 4. Effects of AA added during the differentiation phase of 3T3-L1 cells on expression of C/Ebpβ and C/Ebpδ. (A) Experimental procedure. We seeded 3T3-L1 cells (2 × 105/dish) in 60 mm dishes containing 4 mL of GM and incubated them until they reached confluence. Thereafter, cells were incubated with DM containing vehicle or AA (50 µM) during the differentiation phase for 6 h. Expression of mRNA for (B) C/Ebpβ and (C) C/Ebpδ determined by RT-qPCR. Data are shown as means ± SEM of n = 3 experiments for (B,C). * p < 0.05 vs. control (vehicle in DM) (Student t-tests). GM, growth medium; DM, differentiation medium; AA, arachidonic acid; C/Ebpβ, CCAAT/enhancer-binding protein-β; C/Ebpδ, CCAAT/enhancer-binding protein-δ; SEM, standard error of the mean.
Life 13 00367 g004
Life 13 00367 g005 550
Figure 5. Effects of AA added during the differentiation phase of 3T3-L1 cells on expression of Pparγ and C/Ebpα. (A) Experimental procedure. We seeded 3T3-L1 cells (2 × 105/dish) in 60 mm dishes in 4 mL of GM and incubated them until they reached confluence. Thereafter, cells were incubated with DM containing vehicle or AA (50 µM) during the differentiation phase for 48 h. Expression of mRNA for (B) Pparγ and (C) C/Ebpα determined by RT-qPCR. Data are shown as means ± SEM of n = 3 experiments for (B,C). * p < 0.05 vs. control (vehicle in DM) (Student t-tests). GM, growth medium; DM, differentiation medium; AA, arachidonic acid; Pparγ, proliferator-activated receptor-γ; C/Ebpα, CCAAT/enhancer-binding protein-α; SEM, standard error of the mean.
Figure 5. Effects of AA added during the differentiation phase of 3T3-L1 cells on expression of Pparγ and C/Ebpα. (A) Experimental procedure. We seeded 3T3-L1 cells (2 × 105/dish) in 60 mm dishes in 4 mL of GM and incubated them until they reached confluence. Thereafter, cells were incubated with DM containing vehicle or AA (50 µM) during the differentiation phase for 48 h. Expression of mRNA for (B) Pparγ and (C) C/Ebpα determined by RT-qPCR. Data are shown as means ± SEM of n = 3 experiments for (B,C). * p < 0.05 vs. control (vehicle in DM) (Student t-tests). GM, growth medium; DM, differentiation medium; AA, arachidonic acid; Pparγ, proliferator-activated receptor-γ; C/Ebpα, CCAAT/enhancer-binding protein-α; SEM, standard error of the mean.
Life 13 00367 g005
Life 13 00367 g006 550
Figure 6. Effects of AA added during the differentiation phase of 3T3-L1 cells on expression of Lpl, Glut4, and Leptin. (A) Experimental procedure. We seeded 3T3-L1 cells (2 × 105/dish) in 60 mm dishes containing 4 mL of GM and incubated them until they reached confluence. Thereafter, cells were incubated with DM-containing vehicle or AA (50 µM) during the differentiation phase, followed by 6 days in fresh MM that was replaced every 2 days. Expression of mRNA for (B) Lpl, (C) Glut4, and (D) Leptin determined by RT-qPCR. Data are shown as means ± SEM of n = 3 experiments for (B–D). * p < 0.05 vs. control (vehicle in DM) (Student t-tests). GM, growth medium; DM, differentiation medium; MM, maturation medium; AA, arachidonic acid; Lpl, lipoprotein lipase; Glut4, glucose transporter 4; SEM, standard error of the mean.
Figure 6. Effects of AA added during the differentiation phase of 3T3-L1 cells on expression of Lpl, Glut4, and Leptin. (A) Experimental procedure. We seeded 3T3-L1 cells (2 × 105/dish) in 60 mm dishes containing 4 mL of GM and incubated them until they reached confluence. Thereafter, cells were incubated with DM-containing vehicle or AA (50 µM) during the differentiation phase, followed by 6 days in fresh MM that was replaced every 2 days. Expression of mRNA for (B) Lpl, (C) Glut4, and (D) Leptin determined by RT-qPCR. Data are shown as means ± SEM of n = 3 experiments for (B–D). * p < 0.05 vs. control (vehicle in DM) (Student t-tests). GM, growth medium; DM, differentiation medium; MM, maturation medium; AA, arachidonic acid; Lpl, lipoprotein lipase; Glut4, glucose transporter 4; SEM, standard error of the mean.
Life 13 00367 g006
Life 13 00367 g007 550
Figure 7. Effects of PGI2 or Δ12-PGJ2 on 3T3-L1 cells incubated with AA during the differentiation phase of 3T3-L1 cells. (A) Experimental procedure. We seeded and incubated 3T3-L1 cells (1 × 105/dish) in 35 mm dishes in 2 mL of GM until they reached 100% confluence. The cells were then incubated for 48 h with 2 mL of DM containing vehicle, AA (50 µM), and PGI2.Na (100 nM) or Δ12-PGJ2 (1 µM). The differentiation medium was replaced with 2 mL of fresh MM every 2 days thereafter. Intracellular TAG levels were analyzed in terminally differentiated mature adipocytes on day 10. (B) Intracellular TAG levels in cultured adipocytes. Data are shown as means ± SEM of n = 3 experiments for (B). * p < 0.05 vs. control (vehicle in DM) (Tukey-Kramer tests). GM, growth medium; DM, differentiation medium; MM, maturation medium; AA, arachidonic acid; PGI2.Na, prostaglandin I2.Na; Δ12-PGJ2, Δ12-prostaglandin J2; TAG, triacylglycerol; SEM, standard error of the mean.
Figure 7. Effects of PGI2 or Δ12-PGJ2 on 3T3-L1 cells incubated with AA during the differentiation phase of 3T3-L1 cells. (A) Experimental procedure. We seeded and incubated 3T3-L1 cells (1 × 105/dish) in 35 mm dishes in 2 mL of GM until they reached 100% confluence. The cells were then incubated for 48 h with 2 mL of DM containing vehicle, AA (50 µM), and PGI2.Na (100 nM) or Δ12-PGJ2 (1 µM). The differentiation medium was replaced with 2 mL of fresh MM every 2 days thereafter. Intracellular TAG levels were analyzed in terminally differentiated mature adipocytes on day 10. (B) Intracellular TAG levels in cultured adipocytes. Data are shown as means ± SEM of n = 3 experiments for (B). * p < 0.05 vs. control (vehicle in DM) (Tukey-Kramer tests). GM, growth medium; DM, differentiation medium; MM, maturation medium; AA, arachidonic acid; PGI2.Na, prostaglandin I2.Na; Δ12-PGJ2, Δ12-prostaglandin J2; TAG, triacylglycerol; SEM, standard error of the mean.
Life 13 00367 g007
Life 13 00367 g008 550
Figure 8. Schematic representation of arachidonic acid function during the differentiation phase of 3T3-L1 cells and subsequent effects on adipogenesis induced by 3-isobutyl-1-methylxanthine, dexamethasone, and insulin. Increased PGE2 and PGF2α production, whereas the reduced PGI2 production together with the suppression of PGI2 and Δ12-PGJ2 actions by arachidonic acid during the differentiation phase inhibited MDI-induced adipogenesis during the maturation phase. C/EBPα, CCAAT/enhancer-binding protein-α; C/EBPβ, CCAAT/enhancer-binding protein-β; C/EBPδ, CCAAT/enhancer-binding protein-δ; DEX, dexamethasone; Ins, insulin; IBMX, 3-isobutyl-1-methylxanthine; PPARγ, peroxisome proliferator-activated receptor-γ; LPL, lipoprotein lipase; GLUT4, glucose transporter 4; PG, prostaglandin.
Figure 8. Schematic representation of arachidonic acid function during the differentiation phase of 3T3-L1 cells and subsequent effects on adipogenesis induced by 3-isobutyl-1-methylxanthine, dexamethasone, and insulin. Increased PGE2 and PGF2α production, whereas the reduced PGI2 production together with the suppression of PGI2 and Δ12-PGJ2 actions by arachidonic acid during the differentiation phase inhibited MDI-induced adipogenesis during the maturation phase. C/EBPα, CCAAT/enhancer-binding protein-α; C/EBPβ, CCAAT/enhancer-binding protein-β; C/EBPδ, CCAAT/enhancer-binding protein-δ; DEX, dexamethasone; Ins, insulin; IBMX, 3-isobutyl-1-methylxanthine; PPARγ, peroxisome proliferator-activated receptor-γ; LPL, lipoprotein lipase; GLUT4, glucose transporter 4; PG, prostaglandin.
Life 13 00367 g008
Table
Table 1. Forward (Fw) and reverse (Rv) primers for target genes.
Table 1. Forward (Fw) and reverse (Rv) primers for target genes.
Target GenesPrimers (5→3′)Length (bp)Tm (°C)Product
Length (bp)
C/EbpβFw: CGGGTTTCGGGACTTGAT1856.9793
Rv: GCCCGGCTGACAGTTACAC1961.03
C/EbpδFw: GACTCCTGCCATGTACGACG2060.53118
Rv: GTTGAAGAGGTCGGCGAAGA2060.04
PparγFw: CTTCGCTGATGCACTGCCTAT2160.81216
Rv: GGGTCAGCTCTTGTGAATGGA2160.00
C/EbpαFw: GCCAAGAAGTCGGTGGACA1959.93110
Rv: GTCTCCACGTTGCGTTGTTT2059.62
LplFw: TTGCAGAGAGAGGACTCGGA2059.96125
Rv: GGAGTTGCACCTGTATGCCT2060.04
Glut4Fw: GGATTCCATCCCACAAGGCA2060.03158
Rv: CCAACACGGCCAAGACATTG2060.04
LeptinFw: TTTCACACACGCAGTCGGTA2059.90149
Rv: CACATTTTGGGAAGGCAGGC2060.04
β-ActinFw: GCGGGCGACGATGCT1559.84197
Rv: TGCCAGATCTTCTCCATGTCG2159.86
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nartey, M.N.N.; Jisaka, M.; Syeda, P.K.; Nishimura, K.; Shimizu, H.; Yokota, K. Arachidonic Acid Added during the Differentiation Phase of 3T3-L1 Cells Exerts Anti-Adipogenic Effect by Reducing the Effects of Pro-Adipogenic Prostaglandins. Life 2023, 13, 367. https://doi.org/10.3390/life13020367

AMA Style

Nartey MNN, Jisaka M, Syeda PK, Nishimura K, Shimizu H, Yokota K. Arachidonic Acid Added during the Differentiation Phase of 3T3-L1 Cells Exerts Anti-Adipogenic Effect by Reducing the Effects of Pro-Adipogenic Prostaglandins. Life. 2023; 13(2):367. https://doi.org/10.3390/life13020367

Chicago/Turabian Style

Nartey, Michael N. N., Mitsuo Jisaka, Pinky Karim Syeda, Kohji Nishimura, Hidehisa Shimizu, and Kazushige Yokota. 2023. "Arachidonic Acid Added during the Differentiation Phase of 3T3-L1 Cells Exerts Anti-Adipogenic Effect by Reducing the Effects of Pro-Adipogenic Prostaglandins" Life 13, no. 2: 367. https://doi.org/10.3390/life13020367

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop